A label-free electronic biosensor for detection of bone turnover markers

Sensors

Volumn 9, Issue 10, 2009, Pages 7957-7969

  Yun, Yeo Heung ^a   Bhattacharya, Amit ^b   Watts, Nelson B ^b   Schulz, Mark J ^a  

^a 705 Engineering Research Center   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Bone turnover marker; Electrochemical impedance; Immunosensor; Label free

Indexed keywords

ANTIBODY BINDING; BONE TURNOVER; DETECTION LIMITS; ELECTROCHEMICAL IMPEDANCE; ELECTROCHEMICAL IMPEDANCE MEASUREMENTS; GOLD ELECTRODES; LABEL FREE; LABEL-FREE IMMUNOSENSOR;

ANTIBODIES; BONE; DIAGNOSIS; GOLD DEPOSITS; IMMUNOSENSORS; ORGANIC POLYMERS; SELF ASSEMBLED MONOLAYERS;

DISEASES;

EID: 70350431518     PISSN: 14248220     EISSN: None     Source Type: Journal    
DOI: 10.3390/s91007957     Document Type: Article

References (34)

1. Seeman, E.; Delmas, P.D. Bone quality-the material and structural basis of bone strength and fragility. N. Engl. J. Med. 2006, 354, 2250-2261.
2. Ryouji, M.; Itsuo, Y.; Masahiko, T.; Yasuyo, H.; Itsuaki, Y.; Rikushi, M. Comparison of various biochemical measurements with bone mineral densitometry and quantitative ultrasound for the assessment of vertebral fracture. J. Bone Miner. Metab. 2000, 18, 158-168.
3. Watts, N.B. Clinical utility of biochemical markers of bone remodeling. Clin. Chem. 1999, 45, 1359-1368.
4. Review and search engine for osteoporosis, Bone Health and Osteoporosis Center: Southington, CT, USA, 2008. Available at: http://www.ucosteoporosis.com/ (accessed 31 May 2008).
5. Burgeson, R.E. Serum cross Laps one step ELISA: first application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Annu. Rev. Cell. Biol. 1998, 4, 552-577.
6. Rosenquist, C.; Fledeliu, C.; Christgau, S.; Pedersen B.J.; Bonde, M.; Qvist, P.; Christiansen, C. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopdptides of type I collagen. Clin. Chem.1998, 44, 2281-2289.
7. Okuno, S.; Inaba, M.; Kitatani, K.; Ishimura, E.; Yamakawa, T.; Nishizawa, Y. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patient. Osteoporosis Int. 2005, 16, 501-509.
8. Ross, P.D. Predicting bone loss and fracture risk with biochemical markers: A review. J. Clin.Dent. 1999, 2, 285-294.
9. Wittich, A.; Casco, C.; Oviedo, A.; Zeni, S.; Nadal, M.; Mautalen, C. Serum determination of C-terminal telopeptide of type 1 collagen (CTx) is a sensitive bone resorption marker in renal osteodystrophy. Bone 2001, 29, 300.
10. Hannon, R.A.; Eastell, R. Bone markers and current laboratory assays. Cancer Treat. Rev. 2006, 32, 7-14.
11. Srivastava, A.K.; Macfarlane, G.; Srivastava, V.P.; Mohan, S.; Baylink, D.J. A new monoclonal antibody ELISA for detection and characterization of C-telopeptide fragments of type I collagen in urine. Calcified Tissue Int. 2001, 69, 327-336.
12. Yun, Y.H.; Bange, A.; Heineman, W.R.; Halsall, H.B.; Shanov, V.N.; Dong, Z.; Pixley, S.; Behbehani, M. A nanotube array immunosensor for direct electrochemical detection of antigen-antibody binding. Sens. Actuat. B 2007, 123, 177-182.
13. Ma, K.S.; Zhou, H.; Zoval J.; Madou, M. DNA hybridization detection by label free versus impedance amplifying label with impedance spectroscopy. Sens. Actuat. B 2006, 114, 58-64.
14. Rodriguez, M.C.; Kawde, A.N.; Wang, J. Aptamer biosensor for label-free impedance spectroscopy detection of proteins based on recognition-induced switching of the surface charge. Chem. Commun. 2005, 4267-4269.
15. Belle, J.T.; Bhavsar, K.; Fairchild, A.; Das, A.; Sweeney, J.; Alford, T.L.; Wang, J.; Bhavanandan, V.P.; Joshi, L. A cytokine immunosensor for multiple sclerosis detection based upon label-free electrochemical impedance spectroscopy. Biosens. Bioelectron. 2007, 23, 428-431.
16. Ding, L.; Du, D.; Wu, J.; Ju, H. A disposable impedance sensor for electrochemical study and monitoring of adhesion and proliferation of K562 leukaemia cells. Electrochem. Commun. 2007, 9, 953-958.
17. Campbell, C.E.; Laane, M.M.; Haugarvoll, E.; Giaever, I. Monitoring viral-induced cell death using electric cell-substrate impedance sensing. Biosens. Bioelectron. 2007, 23, 536-542.
18. Peichl, P.; Griesmacher, A.; Marteau, R.; Hejc, S.; Kumpan, W.; Muller, M.; Broll, H. Serum crosslaps in comparison to serum osteocalcin and urinary bone resorption markers. Clin. Biochem. 2001, 34, 131-139.
19. Terpos, E.; Politou, M.; Rahemtulla, A. The role of markers of bone remodeling in multiple myeloma. Blood Rev. 2005, 19, 125-142.
20. Huang, Y.; Nie, X.M.; Gan, S.L.; Jiang, J.H.; Shen, G.L.; Yu, R.Q. Electrochemical immunosensor of platelet-derived growth factor with aptamer-primed polymerase amplification. Anal. Biochem. 2008, 382, 16-22.
21. Keighley, S.D.; Estrela, P.; Li, P.; Migliorato, P. Optimization of label-free DNA detection with electrochemical impedance spectroscopy using PNA probes. Biosens. Bioelectron. 2008, 24, 912-917.
22. Zhang, Y.; Wang, H.; Nie, J.; Zhang, Y.; Shen, G.; Yu, R. Individually addressable microelectrode arrays fabricated with gold-coated pencil graphite particles for multiplexed and high sensitive impedance immunoassays. Biosens. Bioelectron. 2009, 25, 34-40.
23. Levine, P.M.; Gong, P.; Levicky, R.; Shepard, K.L. Real-time, multiplexed electrochemical DNA detection using an active complementary metal-oxide-semiconductor biosensor array with integrated sensor electronics. Biosens. Bioelectron. 2009, 24, 1995-2001.
24. Deng, C.; Chen, J.; Nie, Z.; Wang, M.; Chu, X.; Chen, X.; Xiao, X.; Lei, C.; Yao S. Impedimetric aptasensor with femtomolar sensitivity based on the enlargement of surface-charged gold nanoparticles. Anal. Chem. 2009, 81, 739-745.
25. Jackson, B.F.; Dyson, P.K.; Lonnell, C.; Verheyen, K.L.; Pfeiffer, D.U.; Price, J.S. Bone biomarkers and risk of fracture in two- and three-year-old Thoroughbreds. Equine Vet. J. 2009, 41, 410-413.
26. Garnero, P.; Hausherr, E.; Chapuy, M.C.; Marcelli, C.; Grandjean, H.; Muller, C.; Cormier, C.; Bréart, G.; Meunier, P.J.; Delmas, P.D. Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study. J. Bone Miner. Res. 1996, 11, 1531-1538.
27. Watts, N.B.; Jenkins, D.K.; Visor, J.M.; Casal, D.C.; Geusens, P. Comparison of bone and total alkaline phosphatase and bone mineral density in postmenopausal osteoporotic women treated with alendronate. Osteoporos Int. 2001, 12, 279-288.
28. Greenspan, S.L.; Parker, R.A.; Ferguson, L.; Rosen, H.N.; Maitland-Ramsey, L.; Karpf, D.B. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial. J. Bone Miner. Res. 1998, 13, 1431-1438.
29. Eastell, R.; Barton, I.; Hannon, R.A.; Chines, A.; Garnero, P.; Delmas, P.D. Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J. Bone Miner. Res. 2003, 18, 1051-1056.
30. Delmas, P.D.; Vrijens, B.; Eastell, R.; Roux, C.; Pols, H.A.; Ringe, J.D.; Grauer. A.; Cahall, D.; Watts, N.B. Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis. J. Clin. Endocrinol. Metab. 2007, 92, 1296-1304.
31. Looker, A.C.; Bauer, D.C.; Chesnut, C.H.; Gundberg, C.M.; Hochberg, M.C.; Klee, G.; Kleerekoper, M.; Watts, N.B.; Bell, N.H. Clinical use of biochemical markers of bone remodeling: current status and future directions. Osteoporos Int. 2000, 11, 467-480.
32. Watts, N.B. Clinical utility of biochemical markers of bone remodeling. Clin. Chem. 1999, 45, 359-1368.
33. Kleerekoper, M.; Camacho, P. Monitoring osteoporosis therapy. Clin. Chem. 2005, 51,2227-2228.
34. Camacho, P.M.; Lopez, N.A. Use of biochamical markers of bone turnover in the management of postmenopausal osteoporosis. Clin. Chem. Lab. Med. 2008, 46, 1345-1357.